To evaluate the evolution of facial edema in the postoperative period after alveolar graft surgeries performed with collagen membrane soaked with recombinant human bone morphogenetic protein-2 (rhBMP-2) in individuals with cleft lip and palate.
Design
Longitudinal prospective.
Setting
Tertiary craniofacial center.
Participants
One hundred fifty individuals submitted to alveolar graft.
Interventions
In the preoperative consultation and 4 days after surgery, the individuals were assessed as to age, professional performing the surgery, duration of the procedure, type of cleft, measurement of facial edema, mouth opening, and global evaluation of the postoperative period.
Main Outcome Measures
Statistical analysis was performed to compare the facial edema and different variables, at a significance level of .05.
Results
The maximum facial edema occurred between 3 and 4 days postoperatively, was inversely proportional to age and mouth opening, greater for female patients compared with male patients, for incomplete unilateral cleft lip and palate compared with other types of clefts, and for surgeon 1 compared with the other surgeons at some moment postoperatively. The surgeries were longer for complete unilateral and bilateral clefts. The difference was statistically significant for these variables.
Conclusions
The facial edema was influenced by the rhBMP-2 used in alveolar graft, and trismus was proportional to the intensity of facial edema.
AbyholmF.E., BerglandO., SembG.Secondary bone grafting of alveolar clefts. A surgical/orthodontic treatment enabling a non-prosthodontic rehabilitation in cleft lip and palate patients. Scand J Plast Reconstr Surg.1981; 15: 127–140.
2.
AlonsoN., TanikawaD.Y., FreitasR.D., CananL., OzawaT.O., RochaD.L.Evaluation of maxillary alveolar reconstruction using a resorbable collagen sponge with recombinant human bone morphogenetic protein-2 in cleft lip and palate patients. Tissue Eng Part C Methods.2010; 16: 1183–1189.
BaylinkD.J., FinkelmanR.D., MohanS.Growth factors to stimulate bone formation. J Bone Miner Res.1993; 8: S565–572.
5.
BenetelloV., SakamotoF.C., GiglioF.M.P., SakaiV.T., CalvoA.M., ModenaK.C., ColombiniB.L., DionísioT.J., LaurisJ.R., FariaF.A.. The selective and non-selective cyclooxygenase inhibitors valdecoxib and piroxicam induce the same postoperative analgesia and control of trismus and swelling after lower third molar removal. Br J Med Biol Res.2007; 40: 1133–1140.
6.
BerglandO., SembG., AbyholmF.E.Elimination of the residual alveolar cleft by secondary bone grafting and subsequent orthodontic treatment. Cleft Palate J.1986; 23: 175–205.
7.
BergmanK., EngstrandT., HilbornJ., OssipovD., PiskounovaS., BowdenT.Injectable cell-free template for bone-tissue formation. J Biomed Mater Res A.2009; 91: 1111e8.
8.
BoyneP.J., SandsN.R.Secondary bone grafting of residual alveolar and palatal clefts. J Oral Surg.1972; 30: 87–92.
9.
CalvoA.M., SakaiV.T., GiglioF.P.M., ModenaK.C.S., BenetelloV., SakamotoF.C., FreireT.M., DionísioT.J., LaurisJ.R., TrindadeA.S.Jr.., . Analgesic and anti-inflammatory dose-response relationship of 7.5 and 15 mg meloxicam after lower third molar removal: a double-blind, randomized, crossover study. Int J Oral Maxillofac Surg.2007; 36: 26–31.
10.
CalvoA.M., SakaiV.T., ModenaK.C.S., ColombiniB.L., GallinaM.C., DionísioT.J., LaurisJ.R.P., SantosC.F.Comparison of the efficacy of etoricoxib and ibuprofen in pain and trismus control after lower third molar removal. Rev Odontol UNICID.2006; 18: 29–36.
11.
CarvalhoR.M.Reparo do defeito alveolar com proteína morfogenética óssea (rhBMP-2) em pacientes com fissura labiopalatina.Bauru, SP: Hospital de Reabilitação de Anomalias Craniofaciais da Universidade de São Paulo; 2011. Dissertation.
12.
ColombiniB.L., ModenaK.C.S., CalvoA.M., SakaiV.T., GiglioF.P.M., DionísioT.J., TrindadeA.S.Jr., LaurisJ.R., SantosC.F.Articaine and mepivacaine efficacy in postoperative analgesia for lower third molar removal: a double-blind, randomized, crossover study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2006; 102: 169–174.
DickinsonB.P., AshleyR.K., WassonK.L., O'HaraC., GabbayJ., HellerJ.B., BradleyJ.P.Reduced morbidity and improved healing with bone morphogenic protein-2 in older patients with alveolar cleft defects. Plast Reconstr Surg.2008; 121: 209–217.
15.
GabkaJ., MatsumuraT.Measuring techniques and clinical testing of an anti-inflammatory agent (tantum) [in German]. Munch Med Wochenschr.1971; 113: 198–203.
16.
GregorioL.V., GiglioF.P., SakaiV.T., ModenaK.C., ColombiniB.L., CalvoA.M., SipertC.R., DionisioT.J., LaurisJ.R., FariaF.A.. A comparison of the clinical anesthetic efficacy of 4% articaine and 0.5% bupivacaine (both with 1: 200,000 epinephrine) for lower third molar removal. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2008; 106: 19–28.
17.
HerfordA.S., BoyneP.J., RawsonR., WilliamsR.P.Bone morphogenetic protein-induced repair of the premaxillary cleft. J Oral Maxillofac Surg.2007; 65: 2136–2141.
18.
HershE.V., LevinL.M., AdamsonD., ChristensenS., KierschT.A., NoveckR., WatsonG2nd, LyonJ.A.Dose-ranging analgesic study of Prosorb diclofenac potassium in postsurgical dental pain. Clin Ther.2004; 26: 1215–1227.
19.
HuppJ.R.Princípios de cirurgia. In: PetersonL.J., EllisE., HuppJ.R., TuckerM.R., eds. Cirurgia Oral e Maxilofacial Contemporânea.São Paulo, Brazil: Elsevier;2005: 45–51.
20.
KhouriR.K., BrownD.M., KoudsiB., DeuneE.G., GilulaL.A., CooleyB.C., ReddiA.H.Repair of calvarial defects with flap tissue: role of bone morphogenetic proteins and competent responding tissues. Plast Reconstr Surg.1996; 98: 103–109.
21.
KingsleyD.M.The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes.1994; 8: 133–146.
22.
KortebeinM.J., NelsonC.L., SadoveA.M.Retrospective analysis of 135 secondary alveolar cleft grafts using iliac or calvarial bone. J Oral Maxillofac Surg.1991; 49: 493–498.
23.
MarkovicA., TodorovicL.Effectiveness of dexamethasone and low-power laser in minimizing oedema after third molar surgery: a clinical trial. Int J Oral Maxillofac Surg.2007; 36: 226–229.
24.
MehraraB.J., RoweN.M., SteinbrechD.S., DudziakM.E., SaadehP.B., McCarthyJ.G., GittesG.K., LongakerM.T.Rat mandibular distraction osteogenesis: II. Molecular analysis of transforming growth factor beta-1 and osteocalcin gene expression. Plast Reconstr Surg.1999; 103: 536–547.
NeoviusE., LembergerM., Docherty SkoghA., HillbornJ., EngstrandT.Alveolar bone healing accompanied by severe swelling in cleft children treated with bone morphogenetic protein-2 delivered by hydrogel. J Plast Reconstr Aesthet Surg.2013; 66: 37–42.
27.
RawashdehM.A., TelfahH.Secondary alveolar bone grafting: the dilemma of donor site selection and morbidity. Br J Oral Maxillofac Surg.2008; 46: 665–670.
28.
SantosC.F., ModenaK.C.S., GiglioF.P.M., SakaiV.T., CalvoA.M., ColombiniB.L., SipertC.R., DionisioT.J., FariaF.A., TrindadeA.S.Jr.., . Epinephrine concentration (1: 100,000 or 1: 200,000) does not affect the clinical efficacy of 4% articaine for lower third molar removal: a double-blind, randomized, crossover study. J Oral Maxillofac Surg.2007; 65: 2445–2452.
29.
Schultze-MosgauS., SchmelzeisenR., FrölichJ.C., SchmeleH.Use of ibuprofen and methylprednisolone for the prevention of pain and swelling after removal of impacted third molars. J Oral Maxillofac Surg.1995; 53: 2–7.
30.
SpringfieldD.S.Autogenous bone grafts: nonvascular and vascular. Orthopedics.1992; 15: 1237–1241.
31.
SwanM.C., GoodacreT.E.Morbidity at the iliac crest donor site following bone grafting of the cleft alveolus. Br J Oral Maxillofac Surg.2006; 44: 129–133.
32.
UristM.R., McLeanF.C.Osteogenic potency and new-bone formation by induction in transplants to the anterior chamber of the eye. J Bone Joint Surg.1952; 34A: 443–476.
ÜstünY., ErdoganO., EsenE., KarsliE.D.Comparison of the effects of 2 doses of methylprednisolone on pain, swelling, and trismus after third molar surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.2003; 96: 535–539.
35.
Van HoutW.M., Mink Van Der MolenA.B., BreugemC.C., KooleR., Van CannE.M.Reconstruction of the alveolar cleft: can growth factor-aided tissue engineering replace autologous bone grafting? A literature review and systematic review of results obtained with bone morphogenetic protein-2. Clin Oral Investig.2011; 15: 297–303.
